Could a Once-Daily pill replace needles for kids with blood clots?
NCT ID NCT07618988
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether the blood thinner pill rivaroxaban works as well as standard injections (enoxaparin) in children aged 6 months to 18 years with deep vein clots. Sixty children were randomly assigned to either the pill or injections for 3 months. The main goal was to see how well the clots cleared up on repeat imaging.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- rivaroxaban
- What this could lead to
- If successful, this could offer a simpler oral treatment option for children with deep vein clots, potentially replacing daily injections.
- What could go wrong
- This is a small, single-center trial with only 60 children, so results may not apply broadly. Bleeding risk remains a concern with any blood thinner.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ain Shams University Children's Hospital
Cairo, 11566, Egypt